Opportunity Information: Apply for RFA GH 18 002

The grant opportunity, titled "Strengthening detection of emerging infectious diseases in India" (RFA GH 18 002), is a U.S. Centers for Disease Control and Prevention (CDC) cooperative agreement designed to expand and deepen work previously started under the Global Health Security Agenda (GHSA) in India. The overall intent is to improve how quickly and accurately emerging and high-impact infectious diseases are detected, understood, and acted on, with an emphasis on strengthening surveillance, diagnostics, and the links between routine public health systems and emergency response structures.

A major focus of the project is acute febrile illness (AFI), which is a common reason people are hospitalized and can be caused by many different pathogens that often look similar at first. The funding supports efforts in selected high-burden areas to identify the specific causes (etiologies) of AFI among hospitalized patients, while also examining associated risk factors and clinical outcomes. In practical terms, this means building stronger clinical and laboratory approaches that can distinguish between different infectious causes of fever, helping clinicians and public health agencies target prevention and response measures more effectively.

Another core component is generating evidence on how people seek care and use health services across selected epidemiological zones in India. By mapping health-seeking behavior and utilization patterns, the project aims to correct for undercounting that happens when surveillance data only reflect those who reach certain facilities. These data are then used to estimate the true burden of disease for key infectious causes, improving the accuracy of public health planning and allowing decision-makers to prioritize interventions based on better population-level evidence rather than incomplete facility-based snapshots.

The opportunity also emphasizes evaluating whether expanded and more advanced diagnostic testing should be implemented at district and sub-district levels, not just in centralized reference laboratories. This includes assessing both the public health impact (for example, earlier detection of outbreaks, improved case confirmation, better targeting of treatment or control measures) and the cost-effectiveness of scaling such testing. The intent is to produce actionable findings that can guide investment decisions, showing where advanced diagnostics provide clear value and where simpler approaches may be more appropriate.

In addition to generating data, the NOFO aims to strengthen the underlying systems that turn surveillance signals into coordinated action. A specific deliverable area is building models for stronger linkages to national and state emergency response mechanisms, alongside broader improvements to laboratory surveillance. This reflects an interest not only in detecting pathogens but also in ensuring that detection triggers timely communication, escalation, and response across different levels of the public health system.

Finally, the grant explicitly incorporates a One Health approach, recognizing that human health is intertwined with animal health and environmental conditions. Under this pillar, the project supports activities that strengthen cross-sector collaboration and help model disease patterns across India, which is especially relevant for emerging infections that may involve zoonotic spillover or ecological drivers. The goal is to improve the ability to anticipate and interpret disease trends by considering how pathogens move between people, animals, and environments, rather than treating human cases in isolation.

Administratively, this is a discretionary funding opportunity using a cooperative agreement mechanism, meaning the CDC would likely have substantial involvement in the project’s direction and implementation compared to a more hands-off grant. The funding opportunity was created on January 19, 2018, with an original closing date of March 20, 2018, and required electronic submission by 5:00 p.m. ET on the due date. The award ceiling listed is $3,000,000, with an expectation of a single award. The activity category is health (CFDA 93.326), and eligibility is listed broadly as "Others," with details intended to be clarified in the full eligibility section of the announcement.

  • The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Strengthening detection of emerging infectious diseases in India" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.326.
  • This funding opportunity was created on Jan 19, 2018.
  • Applicants must submit their applications by Mar 20, 2018 Electronically submitted applications must be submitted no later than 500 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for RFA GH 18 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the title and reference number of this funding opportunity?

The opportunity is titled "Strengthening detection of emerging infectious diseases in India" and is identified as RFA GH 18 002.

Who is offering this grant opportunity?

This is a U.S. Centers for Disease Control and Prevention (CDC) funding opportunity.

What type of award mechanism is being used?

The award is a cooperative agreement. This generally means CDC is expected to have substantial involvement in the project direction and implementation, compared with a more hands-off grant mechanism.

Is this a discretionary or mandatory funding opportunity?

This is described as a discretionary funding opportunity.

What is the overall purpose of the cooperative agreement?

The overall intent is to improve how quickly and accurately emerging and high-impact infectious diseases are detected, understood, and acted on in India. The emphasis is on strengthening surveillance, diagnostics, and the linkages between routine public health systems and emergency response structures.

How does this opportunity relate to the Global Health Security Agenda (GHSA)?

The work is designed to expand and deepen activities previously started under the Global Health Security Agenda (GHSA) in India.

What diseases or syndromes are a major focus of the project?

A major focus is acute febrile illness (AFI), a common reason for hospitalization that can be caused by many pathogens that often look similar early in illness.

What does the project aim to do related to acute febrile illness (AFI)?

In selected high-burden areas, the project supports identifying the specific causes (etiologies) of AFI among hospitalized patients, and examining associated risk factors and clinical outcomes. The practical goal is to strengthen clinical and laboratory approaches that can distinguish among infectious causes of fever.

Why is identifying the etiology of AFI important in this program?

Because many AFI causes present similarly at first, stronger diagnostic and clinical approaches can help clinicians and public health agencies better target prevention and response measures based on the actual pathogen(s) responsible.

What kinds of settings are emphasized for AFI work?

The description highlights work in selected high-burden areas and focuses on hospitalized patients with AFI.

Does the opportunity include activities beyond clinical and lab testing?

Yes. A core component is generating evidence on health-seeking behavior and health service utilization across selected epidemiological zones in India, and using these data to improve disease burden estimates.

What is meant by "health-seeking behavior" and "utilization patterns" in this context?

It refers to understanding how and where people seek care and use health services. The goal is to map patterns across selected epidemiological zones so surveillance interpretation is not limited to only those who reach certain facilities.

Why does the program care about health-seeking behavior data?

Surveillance systems can undercount disease when they only capture cases seen at certain facilities. Health-seeking behavior data are intended to help correct for undercounting and improve estimates of the true burden of disease.

How will the opportunity improve population-level disease burden estimates?

By combining surveillance findings with evidence about care-seeking and service utilization, the project aims to estimate the true burden for key infectious causes rather than relying on incomplete facility-based snapshots.

What does the opportunity say about expanding diagnostic testing beyond reference labs?

The NOFO emphasizes evaluating whether expanded and more advanced diagnostic testing should be implemented at district and sub-district levels, not only in centralized reference laboratories.

What factors are included in evaluating expanded diagnostic testing?

The evaluation is intended to include both public health impact (such as earlier outbreak detection, improved case confirmation, and better targeting of treatment or control measures) and cost-effectiveness when considering scaling advanced diagnostics.

What kinds of "actionable findings" are expected from the diagnostics work?

The intent is to produce findings that guide investment decisions by showing where advanced diagnostics provide clear value and where simpler approaches may be more appropriate.

How does this opportunity address the link between surveillance and response?

It emphasizes strengthening the systems that translate surveillance signals into coordinated action. A specific deliverable area is building models for stronger linkages to national and state emergency response mechanisms, along with broader improvements to laboratory surveillance.

What does "routine public health systems and emergency response structures" mean here?

The opportunity highlights improving the connections between day-to-day surveillance and public health operations and the mechanisms used for escalation, communication, and action during emergencies, so detection triggers timely response.

Does the opportunity include a One Health approach?

Yes. The grant explicitly incorporates a One Health approach, recognizing that human health is intertwined with animal health and environmental conditions.

What does One Health involve for this opportunity?

It supports activities to strengthen cross-sector collaboration and help model disease patterns across India, which is relevant for emerging infections involving zoonotic spillover or ecological drivers.

Why is One Health emphasized for emerging infectious diseases?

Emerging infections may involve transmission between people, animals, and environments. A One Health approach is intended to improve the ability to anticipate and interpret disease trends by considering these interactions rather than treating human cases in isolation.

What is the award ceiling?

The listed award ceiling is $3,000,000.

How many awards are expected?

The opportunity indicates an expectation of a single award.

What is the activity category and CFDA number?

The activity category is health, and the CFDA number listed is 93.326.

Who is eligible to apply?

Eligibility is listed broadly as "Others," with details intended to be clarified in the full eligibility section of the announcement.

When was this funding opportunity created?

It was created on January 19, 2018.

What was the original closing date?

The original closing date was March 20, 2018.

How was the application required to be submitted?

The opportunity required electronic submission.

What was the submission deadline time zone and time?

Applications were due by 5:00 p.m. ET on the due date.

What is the main geographic focus of the project?

The program is focused on India, including selected high-burden areas and selected epidemiological zones within the country.

What are the main system areas this opportunity seeks to strengthen?

Based on the description, the main areas are surveillance, diagnostics, laboratory surveillance, evidence generation for burden estimation, and stronger linkages between detection systems and national/state emergency response mechanisms.

What types of outcomes is this opportunity aiming to improve?

The stated aims include quicker and more accurate detection, improved understanding of infectious disease causes and patterns, better ability to act on surveillance signals, and better-targeted prevention and response measures informed by improved diagnostics and stronger burden estimates.

Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA

Browse more opportunities from the same category: Health

Next opportunity: National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 - Clinical Trial Optional)

Previous opportunity: Long Term Resource Monitoring Program FY 2018

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA GH 18 002

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA GH 18 002) also looked into and applied for these:

Funding Opportunity
Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 18 016

Funding Number: RFA RM 18 016
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $500,000
Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 015

Funding Number: RFA RM 18 015
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $390,000
Evidence-Informed Approaches to Improving Health Outcomes for People Living with HIV Apply for HRSA 18 048

Funding Number: HRSA 18 048
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Rural Quality Improvement Technical Assistance Cooperative Agreement Apply for HRSA 18 036

Funding Number: HRSA 18 036
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Vision Screening in Young Children Apply for HRSA 18 064

Funding Number: HRSA 18 064
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Adolescent and Young Adult Health National Capacity Building Program Apply for HRSA 18 082

Funding Number: HRSA 18 082
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Service Area Competition-Additional Areas (SAC-AA) — Newark, NJ Apply for HRSA 18 108

Funding Number: HRSA 18 108
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
H2O Yemen Apply for APS 72027918APS00001

Funding Number: APS 72027918APS00001
Agency: Agency for International Development
Category: Health
Funding Amount: $9,200,000
Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation's Health Apply for CDC RFA OT18 1802

Funding Number: CDC RFA OT18 1802
Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS
Category: Health
Funding Amount: $150,000,000
State Public Health Approaches to Addressing Arthritis Apply for CDC RFA DP18 1803

Funding Number: CDC RFA DP18 1803
Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP
Category: Health
Funding Amount: $500,000
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 18 600

Funding Number: PAR 18 600
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $600,000
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 18 598

Funding Number: PAR 18 598
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 18 599

Funding Number: PAR 18 599
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $750,000
National Network to Enhance Capacity of State and Local Sexually Transmitted Disease Prevention Programs (NNECS) Apply for CDC RFA PS18 1808

Funding Number: CDC RFA PS18 1808
Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP
Category: Health
Funding Amount: $5,000,000
Improving Sexually Transmitted Infection Screening and Treatment among People Living with or at Risk for HIV Apply for HRSA 18 040

Funding Number: HRSA 18 040
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
PEPFAR Small Grants Program 2018-2019, U.S. Embassy Maseru Apply for DOS MSU PFSGP FY2018

Funding Number: DOS MSU PFSGP FY2018
Agency: Department of State, U. S. Mission to Lesotho
Category: Health
Funding Amount: $25,000
National Fetal, Infant, and Child Death Review Program Apply for HRSA 18 089

Funding Number: HRSA 18 089
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
PEPFAR Small Grants Program 2018 Capacity Building Apply for DOS MSU PFSMGPCB FY17

Funding Number: DOS MSU PFSMGPCB FY17
Agency: Department of State, U. S. Mission to Lesotho
Category: Health
Funding Amount: $25,000
National Partnerships to Promote Cancer Surveillance Standards and Support Data Quality and Operations of National Program of Cancer Registries Apply for CDC RFA DP18 1802

Funding Number: CDC RFA DP18 1802
Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP
Category: Health
Funding Amount: $1,045,000
Targeted Capacity Expansion - Hispanic/Latino Center for Excellence: (Short Title: Hispanic/Latino COE) Apply for TI 18 012

Funding Number: TI 18 012
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis
Category: Health
Funding Amount: $400,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 18 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: